AYTU vs UDR · rev $66.4M vs P/E 26, rev $1.71B
Aytu BioScience Inc (AYTU) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
AYTU currently screens at market cap $24.1M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the AYTU and UDR stock pages for the full models.
Not investment advice.